These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 16642030

  • 1. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
    Qian HS, Liu P, Huw LY, Orme A, Halks-Miller M, Hill SM, Jin F, Kretschmer P, Blasko E, Cashion L, Szymanski P, Vergona R, Harkins R, Yu J, Sessa WC, Dole WP, Rubanyi GM, Kauser K.
    Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
    [Abstract] [Full Text] [Related]

  • 2. Age-dependent acceleration of ischemic injury in endothelial nitric oxide synthase-deficient mice: potential role of impaired VEGF receptor 2 expression.
    Qian HS, de Resende MM, Beausejour C, Huw LY, Liu P, Rubanyi GM, Kauser K.
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):587-93. PubMed ID: 16680073
    [Abstract] [Full Text] [Related]

  • 3. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K, Ishibashi M, Ohtani K, Inoue S, Zhao Q, Kitamoto S, Sata M, Ichiki T, Takeshita A, Egashira K.
    Circulation; 2004 May 25; 109(20):2454-61. PubMed ID: 15148275
    [Abstract] [Full Text] [Related]

  • 4. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O.
    Circ Res; 2004 Jul 23; 95(2):154-61. PubMed ID: 15205364
    [Abstract] [Full Text] [Related]

  • 5. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, Nagai R.
    Arterioscler Thromb Vasc Biol; 2010 Jul 23; 30(7):1315-24. PubMed ID: 20413734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model.
    Urano T, Ito Y, Akao M, Sawa T, Miyata K, Tabata M, Morisada T, Hato T, Yano M, Kadomatsu T, Yasunaga K, Shibata R, Murohara T, Akaike T, Tanihara H, Suda T, Oike Y.
    Arterioscler Thromb Vasc Biol; 2008 May 23; 28(5):827-34. PubMed ID: 18258819
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium.
    Kubo M, Egashira K, Inoue T, Koga J, Oda S, Chen L, Nakano K, Matoba T, Kawashima Y, Hara K, Tsujimoto H, Sueishi K, Tominaga R, Sunagawa K.
    Arterioscler Thromb Vasc Biol; 2009 Jun 23; 29(6):796-801. PubMed ID: 19325146
    [Abstract] [Full Text] [Related]

  • 9. Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb.
    Rokutanda T, Izumiya Y, Miura M, Fukuda S, Shimada K, Izumi Y, Nakamura Y, Araki S, Hanatani S, Matsubara J, Nakamura T, Kataoka K, Yasuda O, Kaikita K, Sugiyama S, Kim-Mitsuyama S, Yoshikawa J, Fujita M, Yoshiyama M, Ogawa H.
    Arterioscler Thromb Vasc Biol; 2011 Dec 23; 31(12):2872-80. PubMed ID: 21940947
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T.
    Gene Ther; 2001 Feb 23; 8(3):181-9. PubMed ID: 11313789
    [Abstract] [Full Text] [Related]

  • 11. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH.
    Diabetes; 2007 Mar 23; 56(3):656-65. PubMed ID: 17327433
    [Abstract] [Full Text] [Related]

  • 12. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH.
    Circ Res; 2007 Oct 26; 101(9):948-56. PubMed ID: 17823371
    [Abstract] [Full Text] [Related]

  • 13. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
    Schgoer W, Theurl M, Jeschke J, Beer AG, Albrecht K, Gander R, Rong S, Vasiljevic D, Egger M, Wolf AM, Frauscher S, Koller B, Tancevski I, Patsch JR, Schratzberger P, Piza-Katzer H, Ritsch A, Bahlmann FH, Fischer-Colbrie R, Wolf D, Kirchmair R.
    Circ Res; 2009 Nov 06; 105(10):994-1002. PubMed ID: 19797703
    [Abstract] [Full Text] [Related]

  • 14. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
    Qi X, Okamoto Y, Murakawa T, Wang F, Oyama O, Ohkawa R, Yoshioka K, Du W, Sugimoto N, Yatomi Y, Takuwa N, Takuwa Y.
    Eur J Pharmacol; 2010 May 25; 634(1-3):121-31. PubMed ID: 20206620
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
    Nagahama R, Matoba T, Nakano K, Kim-Mitsuyama S, Sunagawa K, Egashira K.
    Arterioscler Thromb Vasc Biol; 2012 Oct 25; 32(10):2427-34. PubMed ID: 22879581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
    Sugano M, Tsuchida K, Makino N.
    Circulation; 2004 Feb 17; 109(6):797-802. PubMed ID: 14970118
    [Abstract] [Full Text] [Related]

  • 19. [Experimental study on treatment of acute limb ischemia with vascular endothelial growth factor-121 gene transfer].
    Zheng ZH, Xu L, Fan XH.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 Mar 17; 18(2):142-5. PubMed ID: 15065417
    [Abstract] [Full Text] [Related]

  • 20. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
    Dulak J, Józkowicz A, Guevara I, Dembińska-Kieć A.
    Pol J Pharmacol; 1999 Mar 17; 51(3):233-41. PubMed ID: 10600037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.